NVP-ACC789
NVP-ACC789 is an inhibitor of human VEGFR-1, VEGFR-2 (mouse VEGFR-2), VEGFR-3 and PDGFR-β with IC50s of 0.38, 0.02 (0.23), 0.18, 1.4 μM, respectively.
Product Specifications
CAS Number
[300842-64-2]
Product Name Alternative
ACC-789; ZK202650
UNSPSC
12352005
Hazard Statement
H315, H317, H318, H334, H335, H341, H361, H370, H413
Target
PDGFR; VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/NVP-ACC789.html
Concentration
10mM
Purity
99.52
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C4=C2C=CC=C4)C=C1Br
Molecular Formula
C21H17BrN4
Molecular Weight
405.29
Precautions
H315, H317, H318, H334, H335, H341, H361, H370, H413
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDGFRβ; VEGFR1/Flt-1; VEGFR2/KDR/Flk-1; VEGFR3/Flt-4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TAL1, phosphorylated (pT90) (TAL1, BHLHA17, SCL, TCL5, T-cell acute lymphocytic leukemia protein 1, Class A basic helix-loop-helix protein 17, Stem cell protein, T-cell leukemia/lymphoma protein 5) (APC) discontinued
BAFF Receptor (BAFFR, BAFF-R, B Cell-Activating Factor Receptor, BLyS Receptor 3, BR3, CD268, CD268 Antigen, MGC138235, Tumor Necrosis Factor Receptor Superfamily Member 13C, TNFRSF13C) (MaxLight 650)